<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>IR-A radiation &#8211; von Ardenne hyperthermia</title>
	<atom:link href="https://ardenneiratherm.com/es/tag/ir-a-radiation/feed/" rel="self" type="application/rss+xml" />
	<link>https://ardenneiratherm.com/es/</link>
	<description>Premium WBH wIRA hyperthermia devices</description>
	<lastBuildDate>Mon, 13 Oct 2025 13:08:13 +0000</lastBuildDate>
	<language>es</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://ardenneiratherm.com/wp-content/uploads/2025/10/cropped-von-ardenne-iratherm-logo-32x32.jpeg</url>
	<title>IR-A radiation &#8211; von Ardenne hyperthermia</title>
	<link>https://ardenneiratherm.com/es/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Whole-Body Hyperthermia (WBH) as Adjuvant Therapy for Chronic Dorsalgia and Analgesic Abuse</title>
		<link>https://ardenneiratherm.com/es/whole-body-hyperthermia-wbh-chronic-dorsalgia/</link>
					<comments>https://ardenneiratherm.com/es/whole-body-hyperthermia-wbh-chronic-dorsalgia/#respond</comments>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Mon, 13 Oct 2025 13:08:13 +0000</pubDate>
				<category><![CDATA[WBH wIRA-pathologies]]></category>
		<category><![CDATA[analgesic]]></category>
		<category><![CDATA[Dorsalgia]]></category>
		<category><![CDATA[IR-A radiation]]></category>
		<category><![CDATA[pain management]]></category>
		<category><![CDATA[Whole-Body Hyperthermia]]></category>
		<category><![CDATA[wIRA]]></category>
		<category><![CDATA[wIRA hyperthermia]]></category>
		<guid isPermaLink="false">https://ardenneiratherm.com/whole-body-hyperthermia-wbh-chronic-dorsalgia/</guid>

					<description><![CDATA[Whole-Body Hyperthermia (WBH) as Adjuvant Therapy for Chronic Dorsalgia and Analgesic Abuse Published: 2025-10-14 &#124; Last Reviewed: 2025-10-14 Author: M.Sc. Cristian Gologan . Reviewed by: [Dr. Iatan Veronica]. **Medical Disclaimer: This article is for informational purposes only. Consult a physician for chronic back pain diagnosis and treatment.** 1. WBH in Multimodal Pain Therapy for Chronic<br><a class="moretag" href="https://ardenneiratherm.com/es/whole-body-hyperthermia-wbh-chronic-dorsalgia/">+ Read More</a>]]></description>
										<content:encoded><![CDATA[<article>
<header>
<h1>Whole-Body Hyperthermia (WBH) as Adjuvant Therapy for Chronic Dorsalgia and Analgesic Abuse</h1>
<p><strong><span style="color: #6a6a6a;">Published: 2025-10-14 | Last Reviewed: 2025-10-14</span></strong></p>
</header>
<div class="authors">Author:<a href="https://ardenneiratherm.com/es/our-team/cristian-gologan/"> M.Sc. Cristian Gologan</a> . Reviewed by: [<a href="https://ardenneiratherm.com/es/our-team/veronica-iatan/">Dr. Iatan Veronica</a>].</div>
<section class="disclaimer">**Medical Disclaimer: This article is for informational purposes only. Consult a physician for chronic back pain diagnosis and treatment.**</section>
<section>
<h2>1. WBH in Multimodal Pain Therapy for Chronic Non-Specific Low Back Pain</h2>
<p><a href="https://www.dght-ev.de/static/files/62138c2232fb762138c3cdc457.pdf" target="_blank" rel="noopener"><strong>Mild Whole-Body Hyperthermia (WBH)</strong></a>, often mediated by <strong>water-filtered Infrared-A (IR-A)</strong>, serves as an effective adjuvant component in *<strong>stationary multimodal pain therapy</strong>* for patients suffering from *<strong>chronic non-specific low back pain (Dorsalgia)</strong>* <span class="citation">[2]</span>. By inducing controlled, therapeutic heat, WBH supports muscle relaxation, improves local perfusion, and provides <strong>an important, non-pharmacological pathway for managing pain,</strong> particularly in cases involving *<strong>analgesic abuse</strong>* <span class="citation">[1]</span>.</p>
<h3>Clinical Evidence and Application</h3>
<p>The role of WBH in treating chronic back pain is supported by focused clinical evaluations:</p>
<ul>
<li>*<strong>Multimodal Integration:</strong>* A dedicated evaluation confirmed that *<strong>mild WBH</strong>* combined with stationary multimodal pain therapy showed <strong>positive outcomes</strong> in patients with *<strong>chronic non-specific lumbar back pain</strong>* <span class="citation">[2]</span>.</li>
<li>*<strong>Addressing Analgesic Abuse:</strong>* Studies have specifically explored the application of wIRA hyperthermia in patients presenting with *<strong>analgesic abuse</strong>* due to chronic back pain, suggesting its role as <strong>a necessary intervention to reduce pharmacological dependency</strong> <span class="citation">[1]</span>.</li>
<li>*<strong>Mechanism:</strong>* The physical effects of heat—muscle relaxation and increased local circulation—are central to its efficacy in managing this type of musculoskeletal pain.</li>
</ul>
</section>
<section class="faq">
<section>
<h3>Overview of recommended WBH sessions with <a href="https://ardenneiratherm.com/es/dispositivo-de-hipertermia-ardenne-iratherm/">von Ardenne Iratherm 1000 WBH wIRA device</a> and target temperatures</h3>
<p><i>Treatments </i><i>shall</i> <i>only</i> <i>be</i> <i>performed</i><i> after final </i><i>consultation</i> <i>with</i><i> a </i><i>medical</i> <i>doctor</i></p>
<div class="table-scroll-wrapper" >
<table width="1151">
<tbody>
<tr>
<td width="278">Indication</td>
<td width="99">No. of sessions</td>
<td width="135">Target temperature</td>
<td colspan="2" width="309">Therapy time</p>
<p>Increase phase          Plateau phase</td>
<td width="164">Rest time</p>
<p>Resting phase</td>
<td width="164"><b>Total</b></p>
<p><b>WBH </b><b>session</b><b> time</b></td>
</tr>
<tr>
<td rowspan="2" width="278">Dorsalgia</td>
<td rowspan="2" width="99">6</td>
<td rowspan="2" width="135">38.4 °C</td>
<td colspan="2" width="309"><b>60 min</b></td>
<td rowspan="2" width="164">30 min</td>
<td rowspan="2" width="164"><b>~ 90 min</b></td>
</tr>
<tr>
<td width="155">45 min</td>
<td width="155">15 min</td>
</tr>
</tbody>
</table>
</div>
<p>&nbsp;</p>
</section>
<section class="faq">
<h2></h2>
</section>
<h2>Frequently Asked Questions (FAQ)</h2>
<div class="faq-item">
<h3>Can WBH help patients with chronic back pain who abuse painkillers?</h3>
<div>
<p>Yes. wIR-A hyperthermia has been successfully applied to patients with *analgesic abuse* resulting from chronic back pain, providing an effective physical therapy alternative to help manage pain <span class="citation">[1]</span>.</p>
<section class="faq">
<div class="faq-item">
<div>
<h3>Can Whole-Body Hyperthermia with wIRA be used for other pathologies?</h3>
<p>Yes. Other benefits and areas of application of Whole Body Hyperthermia include <strong><a href="https://ardenneiratherm.com/es/ensayos-clinicos-hipertermia-oncologia/">Oncology, accelerated metabolism , stimulation of the hormonal system , reduction in muscle tone , enhanced nerve conduction, Systemic sclerosis, Depressive episode, Essential (primary) hypertension, Dorsalgia, Fibromyalgia, Ankylosing spondylitis</a></strong></p>
<p>A more detailed list of studies and effects ( (<em>from foundational studies on wIRA technology to crucial Phase III clinical trials</em>) can be found <a href="https://ardenneiratherm.com/es/ensayos-clinicos-hipertermia-oncologia/">here</a></p>
<div>
<p>&nbsp;</p>
</div>
<div id="attachment_612" style="width: 1034px" class="wp-caption aligncenter"><a href="https://ardenneiratherm.com/es/ensayos-clinicos-hipertermia-oncologia/"><img fetchpriority="high" decoding="async" aria-describedby="caption-attachment-612" class="wp-image-612 size-large" src="https://ardenneiratherm.com/wp-content/uploads/2025/10/von-Ardenne-Iratherm-10000-WBH-wIRA-hyperthermia-device-summary-1024x529.jpg" alt="von Ardenne Iratherm 10000 Whole-Body Hyperthermia wIRA hyperthermia-device-summary" width="1024" height="529" srcset="https://ardenneiratherm.com/wp-content/uploads/2025/10/von-Ardenne-Iratherm-10000-WBH-wIRA-hyperthermia-device-summary-1024x529.jpg 1024w, https://ardenneiratherm.com/wp-content/uploads/2025/10/von-Ardenne-Iratherm-10000-WBH-wIRA-hyperthermia-device-summary-300x155.jpg 300w, https://ardenneiratherm.com/wp-content/uploads/2025/10/von-Ardenne-Iratherm-10000-WBH-wIRA-hyperthermia-device-summary-768x397.jpg 768w, https://ardenneiratherm.com/wp-content/uploads/2025/10/von-Ardenne-Iratherm-10000-WBH-wIRA-hyperthermia-device-summary.jpg 1414w" sizes="(max-width: 1024px) 100vw, 1024px" /></a><p id="caption-attachment-612" class="wp-caption-text">von Ardenne Iratherm 10000 WBH wIRA hyperthermia-device-summary</p></div>
</div>
</div>
</section>
<section>
<h2></h2>
</section>
</div>
</div>
</section>
<section>
<h2>References (E-E-A-T)</h2>
<ol>
<li><em>Weller E., Ullrich D.</em><br />
<strong>Infrarot-A-Hyperthermie-Anwendung bei Patienten mit Analgetica-Abusus wegen chronischer Rückenschmerzen.</strong><br />
Vortrag auf dem 95. Kongreß der Gesellschaft für Phys Med und Rehab 5.10.1990</li>
<li><em>Ettrich U., Konrad B., Prate K., Seifert J., Krummenauer F.</em><br />
<strong>Milde Ganzkörperhyperthermie in Kombination mit stationärer multimodal orientierter Schmerztherapie – Evaluation bei Patienten mit chronischem unspezifischem lumbalem Rückenschmerz.</strong><br />
Orthopäde 2014; 2:165-74</li>
</ol>
</section>
</article>
]]></content:encoded>
					
					<wfw:commentRss>https://ardenneiratherm.com/es/whole-body-hyperthermia-wbh-chronic-dorsalgia/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Whole-Body Hyperthermia WBH for Primary Hypertension &#038; Cardiovascular diseases</title>
		<link>https://ardenneiratherm.com/es/whole-body-hyperthermia-hypertension-cardio/</link>
					<comments>https://ardenneiratherm.com/es/whole-body-hyperthermia-hypertension-cardio/#respond</comments>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Mon, 13 Oct 2025 12:38:11 +0000</pubDate>
				<category><![CDATA[WBH wIRA-pathologies]]></category>
		<category><![CDATA[blood pressure]]></category>
		<category><![CDATA[blood viscosity]]></category>
		<category><![CDATA[Cardiovascular disease]]></category>
		<category><![CDATA[heart rate]]></category>
		<category><![CDATA[IR-A radiation]]></category>
		<category><![CDATA[mild Whole-Body Hyperthermia]]></category>
		<category><![CDATA[WBH]]></category>
		<category><![CDATA[Whole-Body Hyperthermia]]></category>
		<category><![CDATA[wIRA]]></category>
		<guid isPermaLink="false">https://ardenneiratherm.com/whole-body-hyperthermia-hypertension-cardio/</guid>

					<description><![CDATA[Whole-Body Hyperthermia (WBH) as an Adjuvant Physical Therapy for Primary Hypertension and Cardiovascular Health Published: 2025-10-13 &#124; Last Reviewed: 2025-10-13 Author: Dr. Iatan Veronica . Reviewed by: [M.Sc. Cristian Gologan]. **Medical Disclaimer: This article is for informational purposes only and does not replace the individualized medical consultation, diagnosis, or treatment provided by a licensed physician,<br><a class="moretag" href="https://ardenneiratherm.com/es/whole-body-hyperthermia-hypertension-cardio/">+ Read More</a>]]></description>
										<content:encoded><![CDATA[<article>
<header>
<h1>Whole-Body Hyperthermia (WBH) as an Adjuvant Physical Therapy for Primary Hypertension and Cardiovascular Health</h1>
<p><strong><span style="color: #6a6a6a;">Published: 2025-10-13 | Last Reviewed: 2025-10-13</span></strong></p>
</header>
<div class="authors">
<p>Author: Dr. Iatan Veronica . Reviewed by: [M.Sc. Cristian Gologan].</p>
</div>
<section class="disclaimer">**Medical Disclaimer: This article is for informational purposes only and does not replace the individualized medical consultation, diagnosis, or treatment provided by a licensed physician, especially in the case of cardiovascular diseases.**</section>
<section>
<h2>1. How Does Mild Infrared-A (IR-A) Hyperthermia Influence Primary Hypertension?</h2>
<p><strong>Mild Whole-Body Hyperthermia (WBH)</strong>, mediated by <strong>water-filtered Infrared-A IR-A radiation(wIRA hyperthermia)</strong>, acts as an adjuvant physical therapy for patients with *<strong>Essential Arterial Hypertension</strong>* (WHO stages I and II). Clinical studies indicate that serial WBH sessions positively impact  <strong>central and peripheral pulse waves, blood pressure</strong>, and the <strong>flow properties of blood (viscosity)</strong>, suggesting an overall improvement in hemodynamics and circulatory health <span class="citation">[1, 4]</span>.</p>
<h3>Mechanisms of Action in Arterial Hypertension</h3>
<p>Research on the effects of WBH (especially in the *mild* regimen, below 38.5  degrees C ) has highlighted the following clinical and physiological benefits:</p>
<ol>
<li><strong>Pulse Wave Modulation:</strong> A series of mild IR-A treatments demonstrated the ability to favorably influence *<strong>central and peripheral pulse waves</strong>* in hypertensive patients, indicating a potential improvement in vascular elasticity <span class="citation">[1]</span>.</li>
<li><strong>Blood Viscosity Reduction:</strong> A single WBH session has shown a direct influence on <strong>blood viscosity</strong>, as well as on <strong>*heart rate*</strong> and <strong>*blood pressure*</strong> in patients with Hypertension stages I and II <span class="citation">[4]</span>.</li>
<li><strong>Serial Therapeutic Effect:</strong> Serial irradiations with water-filtered IR-A have been investigated for their effects on patients with Arterial Hypertension, underscoring the role of this method as a valid *<strong>physical therapy</strong>* <span class="citation">[2]</span>.</li>
<li><strong>Predictability of Response:</strong> A single mild  IR-A hyperthermia session can be used to make *<strong>predictions</strong>* regarding a patient&#8217;s response to a complete therapeutic cycle (further treatments) <span class="citation">[5]</span>.</li>
</ol>
</section>
<section>
<h2>2. WBH in Hypertension Treatment (WHO Stages I and II)</h2>
<p>Studies have focused on patients diagnosed with *<strong>Essential Arterial Hypertension</strong>* (Types I and II, according to the WHO classification).</p>
<ul>
<li><strong>Target Group:</strong> Research included patients in the *<strong>early and moderate stages</strong>* of hypertension, showing clear benefits in the context of an adjuvant treatment <span class="citation">[2, 3]</span>.</li>
<li><strong>Physiological Monitoring:</strong> Essential physiological parameters, including <strong>body temperature, heart rate, blood pressure, and blood viscosity</strong>, were closely monitored during and after treatment to quantify acute and cumulative effects <span class="citation">[4]</span>.</li>
<li><strong>Academic Dissertation:</strong> A dedicated study (Diss. Humboldt-Universität Berlin, 1991) specifically analyzed the effects of a single versus serial sessions of *<strong>Infrared-A Hyperthermia</strong>* in HTA Stages I and II patients <span class="citation">[3]</span>.</li>
</ul>
<h3>Overview of recommended WBH sessions with <a href="https://ardenneiratherm.com/es/dispositivo-de-hipertermia-ardenne-iratherm/">von Ardenne Iratherm 1000 WBH wIRA device</a> and target temperatures</h3>
<p><i>Treatments </i><i>shall</i> <i>only</i> <i>be</i> <i>performed</i><i> after final </i><i>consultation</i> <i>with</i><i> a </i><i>medical</i> <i>doctor</i></p>
<div class="table-scroll-wrapper" >
<table width="1151">
<tbody>
<tr>
<td width="278">Indication</td>
<td width="99">No. of sessions</td>
<td width="135">Target temperature</td>
<td colspan="2" width="309">Therapy time</p>
<p>Increase phase          Plateau phase</td>
<td width="164">Rest time</p>
<p>Resting phase</td>
<td width="164"><b>Total</b></p>
<p><b>WBH </b><b>session</b><b> time</b></td>
</tr>
<tr>
<td rowspan="2" width="278">Essential Hypertension</td>
<td rowspan="2" width="99">12</td>
<td rowspan="2" width="135">38.3 °C</td>
<td colspan="2" width="309"><b>30 min</b></td>
<td rowspan="2" width="164">15 min</td>
<td rowspan="2" width="164"><b>~ 45 min</b></td>
</tr>
<tr>
<td width="155">30 min</td>
<td width="155">0 min</td>
</tr>
</tbody>
</table>
</div>
<p>&nbsp;</p>
</section>
<section class="faq">
<h2>Frequently Asked Questions (FAQ) about WBH and Arterial Hypertension</h2>
<div class="faq-item">
<h3>What type of hyperthermia is used for the treatment of hypertension?</h3>
<div>
<p>Primarily *<strong>Mild Whole-Body Hyperthermia Mild WBH, applied using *Infrared-A (IR-A) radiation</strong>*, is utilized for primary hypertension, serving as a non-invasive physical therapy <span class="citation">[2, 4]</span>.</p>
</div>
</div>
<div class="faq-item">
<h3>Does hyperthermia influence blood viscosity?</h3>
<div>
<p>Yes. Studies have shown that a single session of Mild wIRA Hyperthermia can positively influence *<strong>blood viscosity</strong>* (flow properties) in patients with arterial hypertension, contributing to better circulation <span class="citation">[4]</span>.</p>
<h3>Can Whole-Body Hyperthermia with wIRA be used for other pathologies?</h3>
<p>Yes.Other benefits and areas of application of Whole Body Hyperthermia include <strong><a href="https://ardenneiratherm.com/es/ensayos-clinicos-hipertermia-oncologia/">Oncology, accelerated metabolism , stimulation of the hormonal system , reduction in muscle tone , enhanced nerve conduction, Systemic sclerosis, Depressive episode, Essential (primary) hypertension, Dorsalgia, Fibromyalgia, Ankylosing spondylitis</a></strong></p>
<p>A more detailed list of studies and effects ( (<em>from foundational studies on wIRA technology to crucial Phase III clinical trials</em>) can be found <a href="https://ardenneiratherm.com/es/ensayos-clinicos-hipertermia-oncologia/">here</a></p>
<div>
<p>&nbsp;</p>
</div>
<div id="attachment_612" style="width: 1034px" class="wp-caption aligncenter"><a href="https://ardenneiratherm.com/es/ensayos-clinicos-hipertermia-oncologia/"><img fetchpriority="high" decoding="async" aria-describedby="caption-attachment-612" class="wp-image-612 size-large" src="https://ardenneiratherm.com/wp-content/uploads/2025/10/von-Ardenne-Iratherm-10000-WBH-wIRA-hyperthermia-device-summary-1024x529.jpg" alt="von Ardenne Iratherm 10000 Whole-Body Hyperthermia wIRA hyperthermia-device-summary" width="1024" height="529" srcset="https://ardenneiratherm.com/wp-content/uploads/2025/10/von-Ardenne-Iratherm-10000-WBH-wIRA-hyperthermia-device-summary-1024x529.jpg 1024w, https://ardenneiratherm.com/wp-content/uploads/2025/10/von-Ardenne-Iratherm-10000-WBH-wIRA-hyperthermia-device-summary-300x155.jpg 300w, https://ardenneiratherm.com/wp-content/uploads/2025/10/von-Ardenne-Iratherm-10000-WBH-wIRA-hyperthermia-device-summary-768x397.jpg 768w, https://ardenneiratherm.com/wp-content/uploads/2025/10/von-Ardenne-Iratherm-10000-WBH-wIRA-hyperthermia-device-summary.jpg 1414w" sizes="(max-width: 1024px) 100vw, 1024px" /></a><p id="caption-attachment-612" class="wp-caption-text">von Ardenne Iratherm 10000 WBH wIRA hyperthermia-device-summary</p></div>
</div>
</div>
</section>
<section>
<h2>Scientific References (E-E-A-T)</h2>
<ol>
<li id="ref5"><em>Meffert B., Hochmuth O., Steiner M.</em><br />
<strong>Effects of a multiple mild infrared a induced hyperthermia on central and peripheral pulse waves in hypertensive patients.</strong><br />
North Sea Conference on Biomedical Engineering 1990, <a href="https://med.ardenne.de/hyperthermie-2/?lang=en#popmake-6731" target="_blank" rel="noopener">&gt;Abstract</a></li>
<li><em>Meffert H., Scherf HP., Meffert B.</em><br />
<strong>Milde Infrarot-A-Hyperthermie. Auswirkungen von Serienbestrahlungen mit wassergefilterter Infrarotstrahlung auf Gesunde und Kranke mit arterieller Hypertonie bzw. systemischer Sklerodermie.</strong><br />
Akt Dermatol 1993; 19:142-48, <a href="https://med.ardenne.de/hyperthermie-2/?lang=en#popmake-6746" target="_blank" rel="noopener">&gt;Abstract</a>, <a href="https://edoc.hu-berlin.de/bitstream/handle/18452/14171/27X6Iu5oGZL1Y.pdf?sequence=1" target="_blank" rel="noopener noreferrer">Volltext-Link</a></li>
<li><em>Mischke M.</em><br />
<strong>Wirkungen einer einmaligen bzw. seriellen Infrarot-A-Hyperthermie bei Patienten mit arterieller Hypertonie der WHO-Stadien I und II.</strong><br />
Diss. Humboldt-Universität Berlin 18.07.1991</li>
<li><em>Scherf H.P., Meffert H., Bäumler H., Dittmann K., Siewert H., Strangfeld D., Winterfeld H.J., Hecht H.C., Schuhmann E., Sönnichsen N.</em><br />
<strong>Wirkung einer einmaligen milden Infrarot-A-Hyperthermie auf Körpertemperatur, Herzfrequenz, Blutdruck und Blutviskosität bei Gesunden und Patienten mit arterieller Hypertonie der Stadien I und II.</strong><br />
Dermatol Monatsschr 1989; 175:733-40, <a href="https://med.ardenne.de/hyperthermie-2/?lang=en#popmake-6729" target="_blank" rel="noopener">&gt;Abstract</a></li>
<li><em>Scherf H.P., Meffert H., Mischke M., Schollak K.P.</em><br />
<strong>Physikalische Therapie der arteriellen Hypertonie- Eine einmalige milde Infrarot-A-Hyperthermie gestattet Voraussagen hinsichtlich des nsprechens auf weitere Behandlungen.</strong><br />
Phys Rehab Kur Med 1991; 1:38-40, <a href="https://med.ardenne.de/hyperthermie-2/?lang=en#popmake-6733" target="_blank" rel="noopener">&gt;Abstract</a></li>
</ol>
</section>
<footer>© 2025 [Organization Name] All rights reserved. Source: Analysis based on published scientific literature.</footer>
</article>
]]></content:encoded>
					
					<wfw:commentRss>https://ardenneiratherm.com/es/whole-body-hyperthermia-hypertension-cardio/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
